| Financial Year |
March 31 2023 |
| Monetary Funds |
315,691,567.27 |
| Held-for-trading Financial Assets |
6,700,000.00 |
| Notes Receivable |
18,107,598.08 |
| Accounts Receivable |
260,307,313.29 |
| Advances to Suppliers |
2,730,252.60 |
| Other Receivables |
7,712,814.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,434,000.00 |
| Inventories |
117,010,119.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,037,815.35 |
| Total Current Assets |
773,921,137.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
64,811.09 |
| Fixed Assetes |
278,432,873.89 |
| Under-construction Projects |
1,998,691.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,777,517.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,311,641.08 |
| Deferred Income Tax Assets |
4,040,164.37 |
| Other Non-Current Assets |
658,709.86 |
| Sub-Total of Non-Current Assets |
365,448,268.94 |
| Total Assets |
1,139,369,406.04 |
| Short-Term Loans |
58,788,311.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,927,300.00 |
| Accounts Payable |
75,627,895.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,022,467.99 |
| Taxes Payable |
13,042,033.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,765,306.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
338,201.79 |
| Other Current Liabilities |
747,496.74 |
| Sub-Total of Current Liabilities |
176,603,506.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,045,540.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,696,271.95 |
| Total Liabilities |
180,299,778.23 |
| Paid-In Capital(Or Share Stock) |
245,548,776.00 |
| Capital Surplus |
358,551,594.37 |
| Surplus Reserve |
51,887,756.51 |
| LESS:Treasury Stock |
28,083,762.20 |
| Undistributed Profits |
300,183,142.80 |
| Minority Stockholder's Interest |
31,835,586.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
927,234,041.21 |
| Owner's Equity（Stockholder's Equity） |
959,069,627.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,139,369,406.04 |
